Vertex Completes Redemption of Convertible Senior Subordinated Notes

Vertex Completes Redemption of Convertible Senior Subordinated Notes

CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Vertex Pharmaceuticals Incorporated (NAS: VRTX) today announced that it has completed its previously announced call for redemption of $400 million in aggregate principal amount of 3.35% Convertible Senior Subordinated Notes due 2015. Holders of $400 million in aggregate principal amount of the 2015 Notes converted their 2015 Notes into approximately 8.3 million shares of common stock prior to the June 17, 2013 redemption date. With the completion of this transaction, Vertex has no outstanding convertible debt.

About Vertex


Vertex creates new possibilities in medicine. Our team discovers, develops and commercializes innovative therapies so people with serious diseases can lead better lives.

Vertex scientists and our collaborators are working on new medicines to cure or significantly advance the treatment of hepatitis C, cystic fibrosis, rheumatoid arthritis and other life-threatening diseases.

Founded more than 20 years ago in Cambridge, Mass., we now have ongoing worldwide research programs and sites in the U.S., U.K. and Canada. Today, Vertex has more than 2,000 employees around the world, and for three years in a row, Science magazine has named Vertex one of its Top Employers in the life sciences.

(VRTX - GEN)



Vertex (Investors):
Michael Partridge, 617-341-6108
or
Kelly Lewis, 617-961-7530
or
Vertex (Media):
Zach Barber, 617-341-6470
mediainfo@vrtx.com

KEYWORDS:   United States  North America  Massachusetts

INDUSTRY KEYWORDS:

The article Vertex Completes Redemption of Convertible Senior Subordinated Notes originally appeared on Fool.com.

Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.

Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.


Increase your money and finance knowledge from home

Investing in Startups

The lucrative and risky world of startups.

View Course »

Behavioral Finance

Why do investors make the decisions that they do?

View Course »

Add a Comment

*0 / 3000 Character Maximum